Skip to main content
. 2006 May;44(5):1847–1850. doi: 10.1128/JCM.44.5.1847-1850.2006

TABLE 3.

Association between defined clinical risk factors and HCMV reactivation and diseasea

Clinical parameter Control vs HCMV positive Control vs reactivation Control vs disease Reactivation vs disease
Acute GvHD 0.031 1.000 0.001 <0.001
Chronic GvHD 1.000 0.059 0.231 0.003
Corticosteroids (>2 mg/kg) 0.143 0.036 0.452 0.959
CD34+ cell selection 0.242 0.037 0.001 <0.001
CMV serostatus,b +/+ 0.005 <0.001 0.250 0.390
CMV serostatus, +/− 0.006 0.005 0.046 0.552
CMV serostatus, −/+ 0.007 <0.001 0.124 0.817
a

Patients in the control group did not show HCMV reactivation. Significant P values (<0.05) obtained by the Armitage trend test are underlined, and P values of <0.01 are in boldface. Positions of the SNPs in the respective genes were determined at http://snpper.chip.org/.

b

Serostatus of the donor/serostatus of the recipient.